ÂÜÀòÂÒÂ×

Adrien Lemoine is the Co-Founder and Chief Executive Officer of Bloomsbury Genetic Therapies. Before that, Adrien held various leadership positions at companies such as Orchard Therapeutics, Corvidia Therapeutics, AstraZeneca, and GlaxoSmithKline. Adrien's educational background includes an MSc in Engineering and Physical Science in Medicine from Imperial College London and an Engineer Diploma in Physics, telecoms, electrical engineering, and IT from CentraleSupélec.